Unfortunately, this is dead. We will have another trial at a lower dose in 22. Best case scenario is someone partners at a much lower cost to mitigate the risk or most of us are stuck.
Looks like the Nasdq uplist isn't ever going to happen!
This CEO is terrible. I warn new investors here. Very risky play.